哈藥集團(tuán)中藥板塊資源整合研究.pdf

1、哈爾濱工程大學(xué)碩士學(xué)位論文哈藥集團(tuán)中藥板塊資源整合研究姓名：楊玉靜申請(qǐng)學(xué)位級(jí)別：碩士專業(yè)：工商管理碩士（MBA）指導(dǎo)教師：馬永紅201203哈爾濱工程大學(xué)工商管理碩士學(xué)位論文AbstractHarbinPharmaceuticalGroup，asoneofChina’Slargestpharmaceuticalmanufacturergroups，involvesatotalofsevenindustrysegments，includi

2、ngantibioticsandchemotherapyagents，nonprescriptionmedicinesandhealthfood，traditionalChinesemedicine，bioengineeringmedicines，animalvaccinesandveterinarydrugs，andmedicinebusinessItsmainrevenuecomesfromthefirstthreesegments

3、，howevertraditionalChinesemedicinesegment，notstrongenoughtoplayasupportingrole，isstillrelativelyweak，anditisfarbeyondcompetitiveintermsofscale，influence，andbrandvalueInthispaperthetraditionalChinesemedicinesegmentofHarbi

4、nPharmaceuticalGroupissetasthesubjectofthestudyandthedevelopmentstatuswaspresentedAsummaryofadvantagesanddisadvantagesoffoursubcompanieswerereviewedThencombinedwiththewellknownChineseenterprisescontrast，itwaspointedoutth

5、atthedevelopmentoftraditionalChinesemedicinesegmentofHarbinPharmaceuticalGroupisneitherabletosatisfymarketdemand，normeetthemarketcompetitionchallenges，especiallyintheGroup’SoverallstrategiclevelTherefore，forthefoursubcom

6、panies，resourceintegrationisimperative，anditisalsopointedoutthatM&Acouldbeconsideredasafollow_upmovethenInthispaperatheoreticalstudyconcerningresourceintegrationwasconducted，andspecificimplementationplanonHarbinPharmaceu

7、ticalGroup’SproposedintegrationoftraditionalChinesemedicinesegmentwaspresentednewmanagementideasandinitiativesregardingtheintegrationofhuman，financial，material，brand，channel，culturalandotherresourcesareproposedFurthermor

8、e，toensureasuccessfulintegration，guaranteemeasuresareproposed，amorecomprehensiveexpositionoftheresourceintegrationimplementationwithrealisticsignificancewithintheGroupisdiscussedKeywords：TraditionalChineseMedicine；Integr